von Willebrand factor
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La VWF gene provides instructions for making a blood clotting protein called von Willebrand factor. This protein contains regions that attach (bind) to specific cells and proteins during the formation of a blood clot. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La VWF gene provides instructions for making a blood clotting protein called von Willebrand factor. This protein contains regions that attach (bind) to specific cells and proteins during the formation of a blood clot. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.
Von Willebrand factor is made within endothelial cells, which line the inside surface of blood vessels, and bone marrow cells. The factor is made of several identical subunits. To facilitate binding to various cells and proteins, these subunits are cut into smaller pieces by an enzyme called ADAMTS13. Von Willebrand factor helps platelets stick together and adhere to the walls of blood vessels at the site of a wound. These groups of platelets form temporary clots, plugging holes in blood vessel walls to help stop bleeding. Von Willebrand factor also carries another blood clotting protein, coagulation factor VIII, to the area of clot formation.
Conditions referring to this gene or chromosome
Other names
coagulation factor VIII VWF
F8VWF
VWD
Related patient information and medicines

Patient information leaflet
Règles abondantes
When taking one of these me... Some medicines used for chemotherapy can also cause heavy periods. Blood clotting disorders (also known as bleeding disorders) , such as von Willebrand disease, sont rare causes of heavy bleeding. Other symptoms are also likely to develop, such as easy bruising or bleeding from other parts of the body..

Patient information leaflet
Calculateur du taux métabolique basal (TMB)
Open the BMR calculator. What is basal metabolic rate. Your Basal Metabolic Rate (BMR) is the number of calories your body uses to maintain basic functions like breathing, circulation and cell repair - even when you're not doing anything at all. It's the foundation of your daily energy needs and an essential first step in managing your weight,.

Patient information leaflet
Cancers infantiles
Childhood cancer is rare and est much less common than cancer in adults. There are many different type of cancer that can affect children and childhood cancers can cause many different symptoms. Therefore, any child should be seen by a GP or other healthcare professional if you are concerned about any unexplained symptoms. The treatments and.

Patient information leaflet
Crise cardiaque
This part of the heart muscle is at risk of dying unless the blockage is quickly removed. When a part of the heart muscle is damaged it is said to be infarcted. The term myocardial infarction (MI) means damaged heart muscle. If a main coronary artery is blocked, a large part of the heart muscle is affected. If a smaller branch artery is blocked, a.

Patient information leaflet
Hémophilie
Haemophilia is a condition whe... There is no cure but with available treatments most people with haemophilia are able to live normal lives. What is haemophilia. Hémophilie est a rare bleeding disorder caused by deficiency of clotting factors. Clotting factors are present in the blood and are responsible for forming blood clots in response to an.

Patient information leaflet
Leucémie lymphoblastique aiguë
A leukaemia is thought to start first from one abnormal cell. What seems to happen is that certain vital genes which control how cells divide, multiply and die are damaged or altered. This makes the cell abnormal. If the abnormal cell survives it may multiply out of control and develop into a leukaemia. In most cases of ALL, the reason why an.
Lectures complémentaires et références
- von Willebrand factor; MedlinePlus, National Library of Medicine.
- Franchini M, Lippi G. The role of von Willebrand factor in hemorrhagic and thrombotic disorders. Crit Rev Clin Lab Sci. 2007;44(2):115-49. doi: 10.1080/10408360600966753.
- Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood. 2008 Apr 1;111(7):3540-5. doi: 10.1182/blood-2007-11-122945. Epub 2008 Feb 1.
- Pruthi RK. A practical approach to genetic testing for von Willebrand disease. Mayo Clin Proc. 2006 May;81(5):679-91. doi: 10.4065/81.5.679.
- Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res. 2007;120 Suppl 1(Suppl 1):S5-9. doi: 10.1016/j.thromres.2007.03.011. Epub 2007 May 9.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

